DK0502997T3 - Behandling af atopiske sygdomme med gamma-interferon - Google Patents

Behandling af atopiske sygdomme med gamma-interferon

Info

Publication number
DK0502997T3
DK0502997T3 DK91901503.2T DK91901503T DK0502997T3 DK 0502997 T3 DK0502997 T3 DK 0502997T3 DK 91901503 T DK91901503 T DK 91901503T DK 0502997 T3 DK0502997 T3 DK 0502997T3
Authority
DK
Denmark
Prior art keywords
gamma interferon
treatment
atopic diseases
atopic dermatitis
treating patients
Prior art date
Application number
DK91901503.2T
Other languages
Danish (da)
English (en)
Inventor
Donald Y M Leung
Raif S Geha
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23766250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0502997(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK0502997T3 publication Critical patent/DK0502997T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91901503.2T 1989-12-01 1990-11-29 Behandling af atopiske sygdomme med gamma-interferon DK0502997T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44476389A 1989-12-01 1989-12-01

Publications (1)

Publication Number Publication Date
DK0502997T3 true DK0502997T3 (da) 1995-07-17

Family

ID=23766250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91901503.2T DK0502997T3 (da) 1989-12-01 1990-11-29 Behandling af atopiske sygdomme med gamma-interferon

Country Status (8)

Country Link
EP (1) EP0502997B1 (fr)
JP (1) JP2901017B2 (fr)
AT (1) ATE121945T1 (fr)
CA (1) CA2069870E (fr)
DE (1) DE69019163T2 (fr)
DK (1) DK0502997T3 (fr)
ES (1) ES2071977T3 (fr)
WO (1) WO1991007984A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
DK1702623T3 (da) 1998-04-02 2009-01-19 Genentech Inc Anvendelse af interferon-gamma til behandling af hjertehypertrofi
JP2003513933A (ja) * 1999-11-10 2003-04-15 モンドバイオテック・ソシエテ・アノニム 喘息治療用インターフェロンガンマ
JP4435465B2 (ja) * 2002-08-05 2010-03-17 長岡 均 抗アレルギー剤
EP1430902A1 (fr) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
EP0311616B1 (fr) * 1986-06-17 1991-09-25 Biogen, Inc. Combinaisons d'interferons gamma et d'agents anti-inflammatoires ou anti-pyretiques pour le traitement de maladies

Also Published As

Publication number Publication date
JPH05501716A (ja) 1993-04-02
JP2901017B2 (ja) 1999-06-02
DE69019163D1 (de) 1995-06-08
ES2071977T3 (es) 1995-07-01
DE69019163T2 (de) 1995-09-07
ATE121945T1 (de) 1995-05-15
CA2069870E (fr) 2005-01-11
EP0502997B1 (fr) 1995-05-03
CA2069870A1 (fr) 1991-06-02
WO1991007984A1 (fr) 1991-06-13
EP0502997A1 (fr) 1992-09-16
CA2069870C (fr) 2000-08-22

Similar Documents

Publication Publication Date Title
MXPA03010911A (es) Anticuerpos contra ngf para el tratamiento de varios desordenes.
DE60018881D1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
NO883896D0 (no) Konjugater av cytokiner med immunglobuliner.
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
DK0502997T3 (da) Behandling af atopiske sygdomme med gamma-interferon
RU93004982A (ru) Способ лечения эндотоксинового шока с применением антиадгезивных антител
ATE481135T1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
FR2710812B1 (fr) Procédé et installation pour le traitement des semences et des bulbes.
DE3587681D1 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
DE3650505D1 (de) AICA riboside zur prophylaktischen Behandlung von Krankheiten mit einer verminderten Durchblutung.
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
DE59511032D1 (de) Verwendung von notoginsenosid r1 zur behandlung von endotoxinschock oder herzerkrankungen
Warren The control of helminths: nonreplicating infectious agents of man
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
BR9008011A (pt) Processo de tratamento por estiramento de cada fibra individual de qualquer tipo
DE69109314D1 (de) Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen.
DE3681428D1 (de) Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen.
ATE9342T1 (de) Naftidrofuryl-zitrat und seine therapeutische verwendung.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
BR9611033A (pt) Processos para tratar infecção por h.pylori, em um mamífero e para converter a forma coccóide de h. pylori em cultura na forma em espiral e a forma em espiral de h.pylori em cultura na forma coccóide, formulação farmaceutica e uso de um agente capaz de induzir a forma coccóide de h.pylori
SU822822A1 (ru) Способ лечени вибрационной бо-лЕзНи
Gosseye Lissoir et al. The treatment of multiple sclerosis
DE3679255D1 (de) Behandlung chronischer entzuendungskrankheiten.
EP0321094A3 (fr) Traitement des inhibiteurs de facteur VIII